Burden of bacterial antimicrobial resistance in China: a systematic analysis from 1990 to 2021 and projections to 2050
This study assesses the burden of bacterial antimicrobial resistance (AMR) in China from 1990 to 2021 and projects future trends up to 2050. The Global Burden of Disease Study 2021 reveals AMR was attributable to around 160,268 deaths in 2021, with 711,852 fatalities associated with AMR. The most lethal infectious syndrome was bloodstream infections, with MRSA being the principal contributor. Projections suggest that by 2050, AMR could be associated with 769,432 deaths, with 180,123 directly attributable to AMR.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!
